EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive whole-genome sequencing reveals origins of mutational signatures associated with aging, mismatch repair deficiency and temozolomide chemotherapy

Taejoo Hwang iD, Lukasz Karol Sitko, Ratih Khoirunnisa, Fernanda Navarro-Aguad, David M Samuel, Hajoong Park, Banyoon Cheon, Luthfiyyah Mutsnaini, Jaewoong Lee, Burçak Otlu, Shunichi Takeda, Semin Lee und 2 weitere

Nucleic Acids Research · 07.01.2025 · 53 (1)

DOI: 10.1093/nar/gkae1122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 05.12.2024. Verfasst von Taejoo Hwang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), UNIST-gil 50, Ulsan, 44919, Republic of Korea. Hauptthemen laut MEDLINE: DNA Mismatch Repair, Mutation, Antineoplastic Agents, Alkylating, Aging. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute for Basic Science, Ministry of Education, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In a comprehensive study to decipher the multi-layered response to the chemotherapeutic agent temozolomide (TMZ), we analyzed 427 genomes and determined mutational patterns in a collection of ∼40 isogenic DNA repair-deficient human TK6 lymphoblast cell lines. We first demonstrate that the spontaneous mutational background is very similar to the aging-associated mutational signature SBS40 and mainly caused by polymerase zeta-mediated translesion synthesis (TLS). MSH2-/- mismatch repair (MMR) knockout in conjunction with additional repair deficiencies uncovers cryptic mutational patterns. We next report how distinct mutational signatures are induced by TMZ upon sequential inactivation of DNA repair pathways, mirroring the acquisition of chemotherapy resistance by glioblastomas. The most toxic adduct induced by TMZ, O6-meG, is directly repaired by the O6-methylguanine-DNA methyltransferase (MGMT). In MGMT-/- cells, MMR leads to cell death and limits mutagenesis. MMR deficiency results in TMZ resistance, allowing the accumulation of ∼105 C > T substitutions corresponding to signature SBS11. Under these conditions, N3-methyladenine (3-meA), processed by base excision repair (BER), limits cell survival. Without BER, 3-meA is read through via error-prone TLS, causing T > A substitutions but not affecting survival. Blocking BER after abasic site formation results in large deletions and TMZ hypersensitization. Our findings reveal potential vulnerabilities of TMZ-resistant tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Mismatch RepairMutationAntineoplastic Agents, AlkylatingAgingDacarbazineTemozolomideHumansWhole Genome SequencingDrug Resistance, NeoplasmMutS Homolog 2 ProteinDNA Repair EnzymesGenome, HumanCell Line, TumorGlioblastomaDNA Modification MethylasesCell LineTumor Suppressor Proteins

Substanzen

TemozolomideAntineoplastic Agents, AlkylatingMutS Homolog 2 ProteinDNA Repair EnzymesDacarbazineMGMT protein, humanDNA Modification MethylasesMSH2 protein, humanTumor Suppressor Proteins

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), UNIST-gil 50, Ulsan, 44919, Republic of Korea.
  • Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST), UNIST-gil 50, Ulsan 44919, Republic of Korea.
  • Center for Genomic Integrity, Institute for Basic Science, UNIST-gil 50, Ulsan 44919, Republic of Korea.
  • Department of Health Informatics, Graduate School of Informatics, Middle East Technical University, Ankara, Turkey.
  • Guangdong Key Laboratory for Genome Stability & Disease Prevention, Shenzhen University Medical School, 1066 Xueyuan Avenue, Shenzhen, Guangdong 518060, China.
  • Graduate School for Health Sciences and Technology, Ulsan National Institute of Science and Technology (UNIST), UNIST-gil 50, Ulsan, 44919, Republic of Korea.

ORCID-Profile: Taejoo Hwang, Dmitri Ivanov, Anton Gartner

Förderung

  • Institute for Basic Science
  • Ministry of Education
  • National Research Foundation of Korea
  • Ministry of Science and ICT
  • National Natural Science Foundation
  • National Key R&D Program of China

Zitieren

APA

Hwang, T., Sitko, L. K., Khoirunnisa, R., Navarro-Aguad, F., Samuel, D. M., Park, H., Cheon, B., Mutsnaini, L., Lee, J., Otlu, B., Takeda, S., Lee, S., Ivanov, D., & Gartner, A. (2025). Comprehensive whole-genome sequencing reveals origins of mutational signatures associated with aging, mismatch repair deficiency and temozolomide chemotherapy. Nucleic Acids Research, 53(1). https://doi.org/10.1093/nar/gkae1122

Vancouver

Hwang T, Sitko LK, Khoirunnisa R, Navarro-Aguad F, Samuel DM, Park H, et al. Comprehensive whole-genome sequencing reveals origins of mutational signatures associated with aging, mismatch repair deficiency and temozolomide chemotherapy. Nucleic Acids Research. 2025;53(1). doi:10.1093/nar/gkae1122

BibTeX
@article{Hwang2025,
  author = {Hwang, Taejoo and Sitko, Lukasz Karol and Khoirunnisa, Ratih and Navarro-Aguad, Fernanda and Samuel, David M and Park, Hajoong and Cheon, Banyoon and Mutsnaini, Luthfiyyah and Lee, Jaewoong and Otlu, Burçak and Takeda, Shunichi and Lee, Semin and Ivanov, Dmitri and Gartner, Anton},
  title = {Comprehensive whole-genome sequencing reveals origins of mutational signatures associated with aging, mismatch repair deficiency and temozolomide chemotherapy},
  journal = {Nucleic Acids Research},
  year = {2025},
  volume = {53},
  number = {1},
  doi = {10.1093/nar/gkae1122}
}
Kostenlos starten →